You are here

Article Text

Article menu
Download PDFPDF
LETTER
Immunosuppression, IBD, and risk of lymphoma
  1. J R Bebb,
  2. G P Aithal,
  3. R P H Logan
  1. Division of Gastroenterology, University Hospital, Nottingham NG7 2UH, UK
  1. Correspondence to:
    Dr R P H Logan;
    robert.logan{at}nottingham.ac.uk

https://doi.org/10.1136/gut.51.2.296

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with interest the two recent reports of lymphoma in patients with inflammatory bowel disease (IBD) (Farrell et al,Gut 2000;47:514–19 and Palli et al, Gastroenterology 2000;119:647–53). We believe the report from Farrell of four cases of lymphoma in a cohort of 782 patients (of whom 238 had received immunosuppression) considerably overestimates the relative risk of lymphoma in IBD patients. They calculate a relative risk of lymphoma as 31 for the whole cohort and 59 …

    View Full Text

    Linked Articles